JP2008512398A - 人乳強化剤とその製法 - Google Patents
人乳強化剤とその製法 Download PDFInfo
- Publication number
- JP2008512398A JP2008512398A JP2007530567A JP2007530567A JP2008512398A JP 2008512398 A JP2008512398 A JP 2008512398A JP 2007530567 A JP2007530567 A JP 2007530567A JP 2007530567 A JP2007530567 A JP 2007530567A JP 2008512398 A JP2008512398 A JP 2008512398A
- Authority
- JP
- Japan
- Prior art keywords
- milk
- human
- fortifier
- aqueous
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020256 human milk Nutrition 0.000 title claims abstract description 78
- 210000004251 human milk Anatomy 0.000 title claims abstract description 76
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 238000000034 method Methods 0.000 claims abstract description 22
- 230000028327 secretion Effects 0.000 claims abstract description 20
- 230000006651 lactation Effects 0.000 claims abstract description 13
- 230000035935 pregnancy Effects 0.000 claims abstract description 12
- 239000003623 enhancer Substances 0.000 claims abstract description 6
- 235000013336 milk Nutrition 0.000 claims description 84
- 210000004080 milk Anatomy 0.000 claims description 84
- 239000008267 milk Substances 0.000 claims description 83
- 102000004169 proteins and genes Human genes 0.000 claims description 47
- 108090000623 proteins and genes Proteins 0.000 claims description 47
- 235000018102 proteins Nutrition 0.000 claims description 46
- 150000002632 lipids Chemical class 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 20
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 18
- 239000008101 lactose Substances 0.000 claims description 18
- 239000004615 ingredient Substances 0.000 claims description 15
- 235000014633 carbohydrates Nutrition 0.000 claims description 14
- 150000001720 carbohydrates Chemical class 0.000 claims description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 12
- 239000011575 calcium Substances 0.000 claims description 12
- 229910052791 calcium Inorganic materials 0.000 claims description 12
- 238000000108 ultra-filtration Methods 0.000 claims description 12
- 235000015097 nutrients Nutrition 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 238000000926 separation method Methods 0.000 claims description 10
- 238000005119 centrifugation Methods 0.000 claims description 9
- 102000011632 Caseins Human genes 0.000 claims description 8
- 108010076119 Caseins Proteins 0.000 claims description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 8
- 239000011707 mineral Substances 0.000 claims description 8
- 235000010755 mineral Nutrition 0.000 claims description 8
- 230000000153 supplemental effect Effects 0.000 claims description 8
- 239000012745 toughening agent Substances 0.000 claims description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 7
- 241001591005 Siga Species 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 235000013350 formula milk Nutrition 0.000 claims description 7
- 208000018773 low birth weight Diseases 0.000 claims description 7
- 231100000533 low birth weight Toxicity 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- 238000009928 pasteurization Methods 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 108010014251 Muramidase Proteins 0.000 claims description 6
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 6
- 235000020189 fortified milk Nutrition 0.000 claims description 6
- 229960000274 lysozyme Drugs 0.000 claims description 6
- 235000010335 lysozyme Nutrition 0.000 claims description 6
- 239000004325 lysozyme Substances 0.000 claims description 6
- 239000011574 phosphorus Substances 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- 239000005018 casein Substances 0.000 claims description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 4
- 235000021240 caseins Nutrition 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 235000020247 cow milk Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims description 2
- 230000009920 chelation Effects 0.000 claims description 2
- 238000000502 dialysis Methods 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 238000001223 reverse osmosis Methods 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000012744 reinforcing agent Substances 0.000 claims 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 2
- 102000016918 Complement C3 Human genes 0.000 claims 2
- 108010028780 Complement C3 Proteins 0.000 claims 2
- 108010028778 Complement C4 Proteins 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- 102000004407 Lactalbumin Human genes 0.000 claims 2
- 108090000942 Lactalbumin Proteins 0.000 claims 2
- 108010063045 Lactoferrin Proteins 0.000 claims 2
- 102100032241 Lactotransferrin Human genes 0.000 claims 2
- 102100033468 Lysozyme C Human genes 0.000 claims 2
- 102000007562 Serum Albumin Human genes 0.000 claims 2
- 108010071390 Serum Albumin Proteins 0.000 claims 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- 150000004665 fatty acids Chemical class 0.000 claims 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims 2
- 235000021242 lactoferrin Nutrition 0.000 claims 2
- 229940078795 lactoferrin Drugs 0.000 claims 2
- 229920001542 oligosaccharide Polymers 0.000 claims 2
- 150000002482 oligosaccharides Chemical class 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 239000011701 zinc Substances 0.000 claims 2
- 229910052725 zinc Inorganic materials 0.000 claims 2
- 235000021241 α-lactalbumin Nutrition 0.000 claims 2
- 235000021247 β-casein Nutrition 0.000 claims 2
- 235000021246 κ-casein Nutrition 0.000 claims 2
- 241000282412 Homo Species 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 description 18
- 235000016709 nutrition Nutrition 0.000 description 14
- 235000021243 milk fat Nutrition 0.000 description 10
- 239000000047 product Substances 0.000 description 8
- 230000002028 premature Effects 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 5
- 230000032696 parturition Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 102000016943 Muramidase Human genes 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 102000014171 Milk Proteins Human genes 0.000 description 3
- 108010011756 Milk Proteins Proteins 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 238000009295 crossflow filtration Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 235000021073 macronutrients Nutrition 0.000 description 3
- 230000008774 maternal effect Effects 0.000 description 3
- 235000021239 milk protein Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 238000011272 standard treatment Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008902 immunological benefit Effects 0.000 description 1
- 235000020190 lactose-free milk Nutrition 0.000 description 1
- 150000002605 large molecules Chemical group 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013384 milk substitute Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Pediatric Medicine (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dairy Products (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04405567 | 2004-09-10 | ||
| EP04405592A EP1637043A1 (en) | 2004-09-17 | 2004-09-17 | Human milk fortifiers and methods for their production |
| PCT/CH2005/000518 WO2006026878A1 (en) | 2004-09-10 | 2005-09-02 | Human milk fortifiers and methods for their production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008512398A true JP2008512398A (ja) | 2008-04-24 |
| JP2008512398A5 JP2008512398A5 (enExample) | 2012-04-05 |
Family
ID=35511068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007530567A Pending JP2008512398A (ja) | 2004-09-10 | 2005-09-02 | 人乳強化剤とその製法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20080187619A1 (enExample) |
| EP (1) | EP1791444A1 (enExample) |
| JP (1) | JP2008512398A (enExample) |
| AU (1) | AU2005282182A1 (enExample) |
| WO (1) | WO2006026878A1 (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012510476A (ja) * | 2008-12-02 | 2012-05-10 | プロラクタ バイオサイエンス，インコーポレイテッド | ヒト乳透過組成物ならびにその製造および使用方法 |
| JP2016534712A (ja) * | 2013-10-14 | 2016-11-10 | コンシッリョ ナツィオナーレ デッレ リチェルケＣｏｎｓｉｇｌｉｏ Ｎａｚｉｏｎａｌｅ Ｄｅｌｌｅ Ｒｉｃｅｒｃｈｅ | 食品組成物 |
| JP2019505203A (ja) * | 2015-12-30 | 2019-02-28 | プロラクタ バイオサイエンス，インコーポレイテッド | 術前及び術後のケアに有用なヒト乳製品 |
| US12364721B2 (en) | 2019-09-24 | 2025-07-22 | Prolacta Bioscience, Inc. | Compositions and methods for treatment of inflammatory and immune diseases |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100268658A1 (en) * | 2001-05-14 | 2010-10-21 | Prolacta Bioscience | Method for collecting, testing and distributing milk |
| US20020182243A1 (en) * | 2001-05-14 | 2002-12-05 | Medo Elena Maria | Method of producing nutritional products from human milk tissue and compositions thereof |
| JP2008512656A (ja) * | 2004-09-10 | 2008-04-24 | メデラ ホールディング アーゲー | 人乳の分析及び処理方法とそのためのシステム |
| BRPI0616323A2 (pt) | 2005-09-20 | 2011-06-14 | Prolacta Bioscience Inc | mÉtodo para determinar se um fluido mamÁrio doado foi obtido a partir de um indivÍduo especÍfico |
| WO2007116410A2 (en) * | 2006-04-11 | 2007-10-18 | Mileutis Ltd. | Livestock management for improved reproductive efficiency |
| EP2063722B1 (en) * | 2006-08-30 | 2017-05-03 | Prolacta Bioscience, Inc. | Methods of obtaining sterile milk and compositions thereof |
| DK2099321T3 (en) * | 2006-11-29 | 2017-07-17 | Prolacta Bioscience Inc | Human milk compositions and methods for their preparation and use |
| CA2706723C (en) * | 2006-12-08 | 2015-05-19 | Prolacta Bioscience, Inc. | Compositions of human lipids and methods of making and using same |
| EP2248908A1 (en) * | 2009-05-05 | 2010-11-10 | Eurolactis Group S.A. | Probiotic microorganisms isolated from donkey milk |
| DK2739157T3 (en) | 2011-08-03 | 2018-01-08 | Prolacta Bioscience Inc | Microfiltration of human milk to reduce bacterial contamination |
| PT2967094T (pt) | 2013-03-13 | 2021-01-14 | Prolacta Bioscience Inc | Produtos de leite humano com elevado teor de matéria gorda |
| US9661868B2 (en) * | 2013-07-16 | 2017-05-30 | Mead Johnson Nutrition Company | Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin |
| SG10201805732TA (en) * | 2014-01-03 | 2018-08-30 | Elizabeth Rinaldi Schinkel | Method and apparatus for concentrating breast milk |
| EP2957178A1 (en) * | 2014-06-16 | 2015-12-23 | Carag AG | Method and apparatus for preparation of human milk to be stored |
| PL3175238T3 (pl) | 2014-07-28 | 2022-01-17 | Société des Produits Nestlé S.A. | Urządzenia i zestawy do wytwarzania spersonalizowanej, zatężonej kompozycji ludzkiego mleka oraz sposoby jej wytwarzania i stosowania |
| US20230103295A1 (en) * | 2016-12-25 | 2023-04-06 | LactaLogics, Inc. | Processing human milk for generating compositions of fortified human milk products |
| KR102004320B1 (ko) * | 2017-09-20 | 2019-07-29 | 건국대학교 글로컬산학협력단 | 모유은행 기증모유의 동결건조보관 방법 |
| MX2021010118A (es) | 2019-02-22 | 2021-11-12 | Aquero Canada Ltd | Composiciones lacteas fortificadas y sus procesos de preparacion. |
| AU2021263069A1 (en) * | 2020-04-27 | 2022-11-10 | Société des Produits Nestlé S.A. | Method for producing milk like products |
| BR112022021733A2 (pt) * | 2020-04-27 | 2022-12-06 | Nestle Sa | Método para a produção de produtos semelhantes a leite |
| US11206843B1 (en) * | 2020-05-26 | 2021-12-28 | BIOMILQ, Inc. | Milk product compositions |
| WO2022200526A1 (de) * | 2021-03-24 | 2022-09-29 | Ammeva Gmbh | Getrocknete frauenmilch zum einsatz als nahrungsergänzungsmittel, lebensmittel für besondere medizinische zwecke und als alleinnahrungsmittel für säuglinge |
| US20240196949A1 (en) * | 2021-04-06 | 2024-06-20 | John Kapeleris | Infant formula |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6270827B1 (en) * | 1988-09-22 | 2001-08-07 | Gerald E. Gaull | Infant formula compositions and method of making |
| JP2002540806A (ja) * | 1999-04-09 | 2002-12-03 | アボット・ラボラトリーズ | 粉末人乳強化剤 |
| US20020182243A1 (en) * | 2001-05-14 | 2002-12-05 | Medo Elena Maria | Method of producing nutritional products from human milk tissue and compositions thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169666A (en) * | 1991-11-14 | 1992-12-08 | The United States Of America As Represented By The Secretary Of Agriculture | Preparation of simulated human milk protein by low temperature microfiltration |
| US6162472A (en) * | 1998-07-28 | 2000-12-19 | University Of Virginia Patent Foundation | Nutritional formula for premature infants and method of making |
| CA2260673A1 (en) * | 1999-02-04 | 2000-08-04 | Natrel Inc. | A process for making a lactose-free milk without negatively affecting the organoleptic properties thereof; and milk so processed |
| US6875459B2 (en) * | 2001-09-10 | 2005-04-05 | Henry B. Kopf | Method and apparatus for separation of milk, colostrum, and whey |
| JP2008512656A (ja) * | 2004-09-10 | 2008-04-24 | メデラ ホールディング アーゲー | 人乳の分析及び処理方法とそのためのシステム |
-
2005
- 2005-09-02 US US11/662,348 patent/US20080187619A1/en not_active Abandoned
- 2005-09-02 AU AU2005282182A patent/AU2005282182A1/en not_active Abandoned
- 2005-09-02 EP EP05775589A patent/EP1791444A1/en not_active Withdrawn
- 2005-09-02 WO PCT/CH2005/000518 patent/WO2006026878A1/en not_active Ceased
- 2005-09-02 JP JP2007530567A patent/JP2008512398A/ja active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6270827B1 (en) * | 1988-09-22 | 2001-08-07 | Gerald E. Gaull | Infant formula compositions and method of making |
| JP2002540806A (ja) * | 1999-04-09 | 2002-12-03 | アボット・ラボラトリーズ | 粉末人乳強化剤 |
| US20020182243A1 (en) * | 2001-05-14 | 2002-12-05 | Medo Elena Maria | Method of producing nutritional products from human milk tissue and compositions thereof |
Non-Patent Citations (6)
| Title |
|---|
| JPN5007015418; ＢＯＥＨＭ Ｇ: ＡＣＴＡ ＰＡＥＤＩＡＴＲＩＣＡ ＳＣＡＮＤＩＮＡＶＩＣＡ Ｖ７７ Ｎ５, 1988, Ｐ６４２-６４６ * |
| JPN5007015419; ＢＯＥＨＭ Ｇ: ＡＣＴＡ ＰＡＥＤＩＡＴＲＩＣＡ ＨＵＮＧＡＲＩＣＡ Ｖ２６ Ｎ３, 1985, Ｐ２６１-２６９ * |
| JPN5007015420; ＢＯＥＨＭ Ｇ: ＡＣＴＡ ＰＡＥＤＩＡＴＲＩＣＡ ＨＵＮＧＡＲＩＣＡ Ｖ２８ Ｎ３-４, 1987, Ｐ２６７-２７２ * |
| JPN5007015421; ＳＣＨＡＮＬＥＲ Ｒ Ｊ: ＰＥＤＩＡＴＲＩＣ ＲＥＳＥＡＲＣＨ Ｖ２０ Ｎ８, 1986, Ｐ７１１-７１５ * |
| JPN5007015422; ＳＣＨＡＮＬＥＲ Ｒ Ｊ: ＴＨＥ ＪＯＵＲＮＡＬ ＯＦ ＰＥＤＩＡＴＲＩＣＳ Ｖ１０７ Ｎ５, 198511, Ｐ７６７-７７４ * |
| JPN6011043969; 川口茂 他: '極小未熟児における蛋白強化母乳の効果に関する検討' 日本新生児学会雑誌 Ｖｏｌ．２３， Ｎｏ．３, 1987, ｐ．６４０-６４６ * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012510476A (ja) * | 2008-12-02 | 2012-05-10 | プロラクタ バイオサイエンス，インコーポレイテッド | ヒト乳透過組成物ならびにその製造および使用方法 |
| US8927027B2 (en) | 2008-12-02 | 2015-01-06 | Prolacta Bioscience | Human milk permeate compositions and methods of making and using same |
| JP2016534712A (ja) * | 2013-10-14 | 2016-11-10 | コンシッリョ ナツィオナーレ デッレ リチェルケＣｏｎｓｉｇｌｉｏ Ｎａｚｉｏｎａｌｅ Ｄｅｌｌｅ Ｒｉｃｅｒｃｈｅ | 食品組成物 |
| JP2019505203A (ja) * | 2015-12-30 | 2019-02-28 | プロラクタ バイオサイエンス，インコーポレイテッド | 術前及び術後のケアに有用なヒト乳製品 |
| JP2021176325A (ja) * | 2015-12-30 | 2021-11-11 | プロラクタ バイオサイエンス，インコーポレイテッド | 術前及び術後のケアに有用なヒト乳製品 |
| JP7389087B2 (ja) | 2015-12-30 | 2023-11-29 | プロラクタ バイオサイエンス，インコーポレイテッド | 術前及び術後のケアに有用なヒト乳製品 |
| US12364721B2 (en) | 2019-09-24 | 2025-07-22 | Prolacta Bioscience, Inc. | Compositions and methods for treatment of inflammatory and immune diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006026878A1 (en) | 2006-03-16 |
| AU2005282182A1 (en) | 2006-03-16 |
| EP1791444A1 (en) | 2007-06-06 |
| US20080187619A1 (en) | 2008-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008512398A (ja) | 人乳強化剤とその製法 | |
| JP5448819B2 (ja) | 無菌乳およびその組成物を得る方法 | |
| JP2023123559A (ja) | 乳タンパク質および乳糖を含む改善された栄養製品の製造方法ならびにこの方法により得られた製品 | |
| CA2777595C (en) | Allergy treatment using acid treated aqueous whey protein extract | |
| EP1637043A1 (en) | Human milk fortifiers and methods for their production | |
| CN113056207A (zh) | 用于改善肠道成熟的天然乳清蛋白 | |
| Crowley et al. | Potential applications of non‐bovine mammalian milk in infant nutrition | |
| WO2007028210A1 (en) | Milk derived composition and use to enhance muscle mass or muscle strength | |
| US9480717B2 (en) | Composition of whey growth factor extract for reducing muscle inflammation | |
| JP2019076104A (ja) | 食品組成物及びその使用 | |
| CN101014253A (zh) | 人乳强化剂及其生产方法 | |
| EP4057841B1 (en) | Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract | |
| CN116490081A (zh) | 用于改善胃肠耐受性的天然乳清蛋白组合物 | |
| Patel et al. | Milk: Nutrition, health benefits, and its consequences | |
| JP2016506754A (ja) | 食品組成物及び脱水症に対するその使用 | |
| CN116829002A (zh) | 具有高免疫球蛋白含量的乳 | |
| HK40081708B (en) | Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract | |
| HK40081708A (en) | Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract | |
| Milk | Dairy products | |
| Dularia et al. | Membrane Processing Technology–Preparation of Protein Rich Ingredients for Various Health-Promoting Foods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080526 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110823 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111121 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111129 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120220 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20120220 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120925 |